Angiographic trials of lipid-lowering therapy: end of an era?
作者信息
Thompson G R
机构信息
MRC Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London.
出版信息
Br Heart J. 1995 Oct;74(4):343-7. doi: 10.1136/hrt.74.4.343.
Abstract
摘要
相似文献
1
Angiographic trials of lipid-lowering therapy: end of an era?降脂治疗的血管造影试验：一个时代的终结？
Br Heart J. 1995 Oct;74(4):343-7. doi: 10.1136/hrt.74.4.343.
2
Lipids and prevention in coronary care.
Trans Med Soc Lond. 1994;111:43-58.
3
Implications of 4S evidence on baseline lipid levels.
Lancet. 1995 Jul 15;346(8968):181.
4
Implications of 4S evidence on baseline lipid levels.4S研究证据对基线血脂水平的影响。
Lancet. 1995 Jul 15;346(8968):181.
5
Implications of 4S evidence on baseline lipid levels.
Lancet. 1995 Jul 15;346(8968):181-2.
6
Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
Curr Opin Lipidol. 1995 Oct;6(5):251-3.
7
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.斯堪的纳维亚辛伐他汀生存研究（4S）糖尿病受试者亚组分析：对冠心病预防的启示
Diabetes Care. 1997 Apr;20(4):469-71. doi: 10.2337/diacare.20.4.469.
8
[The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].[4S研究——胆固醇争论的转折点。瑞士心脏病学会脂质与动脉粥样硬化工作组]
Praxis (Bern 1994). 1995 Dec 19;84(51-52):1514-6.
9
Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.心脏移植后降胆固醇治疗：一项为期12个月的随机试验。
J Heart Lung Transplant. 1995 Jul-Aug;14(4):613-22.
10
The 4S study: a critical review.4S研究：一项批判性综述。
Pharmacol Res. 1997 Mar;35(3):165-6. doi: 10.1006/phrs.1996.0163.
引用本文的文献
1
A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium.一个冬日故事：首届加拿大生物标志物与替代终点研讨会报告
Can J Cardiol. 2009 Sep;25(9):527-32. doi: 10.1016/s0828-282x(09)70143-6.
本文引用的文献
1
Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.
Annu Rev Med. 1993;44:365-76. doi: 10.1146/annurev.me.44.020193.002053.
2
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS).圣托马斯动脉粥样硬化消退研究（STARS）中血浆脂蛋白亚组分水平与冠状动脉疾病病程之间的独立关联。
Metabolism. 1993 Nov;42(11):1461-7. doi: 10.1016/0026-0495(93)90199-x.
3
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).洛伐他汀治疗的冠状动脉造影改变。动脉粥样硬化监测消退研究（MARS）。
Ann Intern Med. 1993 Nov 15;119(10):969-76. doi: 10.7326/0003-4819-119-10-199311150-00002.
4
Association between lipoprotein(a) and progression of coronary artery disease in middle-aged men.中年男性脂蛋白(a)与冠状动脉疾病进展之间的关联。
Am J Cardiol. 1994 Apr 15;73(11):742-6. doi: 10.1016/0002-9149(94)90874-5.
5
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).强化多重危险因素降低对冠心病男性和女性冠状动脉粥样硬化及临床心脏事件的影响。斯坦福冠状动脉风险干预项目（SCRIP）。
Circulation. 1994 Mar;89(3):975-90. doi: 10.1161/01.cir.89.3.975.
6
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.对于载脂蛋白B升高的男性，降脂治疗的益处并不局限于那些低密度脂蛋白胆固醇水平非常高的男性。
J Am Coll Cardiol. 1994 Mar 15;23(4):899-906. doi: 10.1016/0735-1097(94)90635-1.
7
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.在一项关于洛伐他汀的对照试验中，通过定量冠状动脉造影评估发现，富含甘油三酯和胆固醇的脂蛋白对轻度/中度和重度病变进展有不同影响。
Circulation. 1994 Jul;90(1):42-9. doi: 10.1161/01.cir.90.1.42.
8
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group.血浆胆固醇浓度降低对血脂正常患者冠状动脉粥样硬化的影响。哈佛动脉粥样硬化逆转项目（HARP）研究小组。
Lancet. 1994 Oct 29;344(8931):1182-6. doi: 10.1016/s0140-6736(94)90506-1.
9
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Lancet. 1995 Apr 1;345(8953):811-6. doi: 10.1016/s0140-6736(95)92961-4.
10
Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.苯扎贝特与辛伐他汀联合治疗混合性高脂血症。
QJM. 1995 Jun;88(6):421-7.
Zotero 插件